Skip to main content
Top
Published in: Reviews in Endocrine and Metabolic Disorders 4/2018

01-12-2018

Thyroid diseases and skin autoimmunity

Authors: Enke Baldini, Teresa Odorisio, Chiara Tuccilli, Severino Persechino, Salvatore Sorrenti, Antonio Catania, Daniele Pironi, Giovanni Carbotta, Laura Giacomelli, Stefano Arcieri, Massimo Vergine, Massimo Monti, Salvatore Ulisse

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 4/2018

Login to get access

Abstract

The skin is the largest organ of the body, at the boundary with the outside environment. Primarily, it provides a physical and chemical barrier against external insults, but it can act also as immune organ because it contains a whole host of immune-competent cells of both the innate and the adaptive immune systems, which cooperate in eliminating invading pathogens following tissue injury. On the other hand, improper skin immune responses lead to autoimmune skin diseases (AISD), such as pemphigus, bullous pemphigoid, vitiligo, and alopecia. Although the interplay among genetic, epigenetic, and environmental factors has been shown to play a major role in AISD etiology and progression, the molecular mechanisms underlying disease development are far from being fully elucidated. In this context, epidemiological studies aimed at defining the association of different AISD with other autoimmune pathologies revealed possible shared molecular mechanism(s) responsible for disease progression. In particular, over the last decades, a number of reports have highlighted a significant association between thyroid diseases (TD), mainly autoimmune ones (AITD), and AISD. Here, we will recapitulate the epidemiology, clinical manifestations, and pathogenesis of the main AISD, and we will summarize the epidemiological evidence showing the associations with TD as well as possible molecular mechanism(s) underlying TD and AISD pathological manifestations.
Literature
2.
3.
go back to reference Yoo WS, Chung HK. Recent advances in autoimmune thyroid diseases. Endocrinol Metab. 2016;31:379–85.CrossRef Yoo WS, Chung HK. Recent advances in autoimmune thyroid diseases. Endocrinol Metab. 2016;31:379–85.CrossRef
4.
go back to reference Stassi G, De Maria R. Autoimmune thyroid disease: new model of cell death in autoimmunity. Nat Rev Immunol. 2003;2:195–204.CrossRef Stassi G, De Maria R. Autoimmune thyroid disease: new model of cell death in autoimmunity. Nat Rev Immunol. 2003;2:195–204.CrossRef
5.
go back to reference Gharib M, Gharib H. Guidelines for the diagnosis and management of thyroid nodules. Thyroid Int. 2011;1:3–11. Gharib M, Gharib H. Guidelines for the diagnosis and management of thyroid nodules. Thyroid Int. 2011;1:3–11.
6.
go back to reference Nikiforov YE, Biddinger PW, Thompson LDR. Diagnostic pathology and molecular genetics of the thyroid. Philadelphia: Wolters Kluwer – Lippincott Williams & Wilkins; 2009. Nikiforov YE, Biddinger PW, Thompson LDR. Diagnostic pathology and molecular genetics of the thyroid. Philadelphia: Wolters Kluwer – Lippincott Williams & Wilkins; 2009.
7.
go back to reference Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14:174–80.CrossRefPubMed Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14:174–80.CrossRefPubMed
9.
go back to reference Shukla SK, Singh G, Ahmad S, Pant P. Infections, genetic and environmental factors in pathogenesis of autoimmune thyroid diseases. Microb Pathog. 2018;116:279–88.CrossRefPubMed Shukla SK, Singh G, Ahmad S, Pant P. Infections, genetic and environmental factors in pathogenesis of autoimmune thyroid diseases. Microb Pathog. 2018;116:279–88.CrossRefPubMed
10.
go back to reference Ajjan RA, Weetman AP. The pathogenesis of Hashimoto’s thyroiditis: further developments in our understanding. Horm Metab Res. 2015;47:702–10.CrossRefPubMed Ajjan RA, Weetman AP. The pathogenesis of Hashimoto’s thyroiditis: further developments in our understanding. Horm Metab Res. 2015;47:702–10.CrossRefPubMed
11.
go back to reference Brix TH, Kyvik KO, Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab. 2000;85:536–9.PubMed Brix TH, Kyvik KO, Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab. 2000;85:536–9.PubMed
13.
go back to reference Vaccaro M, Guarneri F, Borgia F, Cannavò SP, Benvenga S. Association of lichen sclerosus and autoimmune thyroiditis: possible role of Borrelia burgdorferi? Thyroid. 2002;12:1147–8.CrossRefPubMed Vaccaro M, Guarneri F, Borgia F, Cannavò SP, Benvenga S. Association of lichen sclerosus and autoimmune thyroiditis: possible role of Borrelia burgdorferi? Thyroid. 2002;12:1147–8.CrossRefPubMed
14.
go back to reference Benvenga S, Guarneri F. Molecular mimicry and autoimmune thyroid disease. Rev Endocr Metab Disord. 2016;17:485–98.CrossRefPubMed Benvenga S, Guarneri F. Molecular mimicry and autoimmune thyroid disease. Rev Endocr Metab Disord. 2016;17:485–98.CrossRefPubMed
15.
go back to reference Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17:1063–72.CrossRefPubMed Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17:1063–72.CrossRefPubMed
16.
go back to reference Cichorek M, Wachulska M, Stasiewicz A, Tymińska A. Skin melanocytes: biology and development. Postepy Dermatol Alergol. 2013:30:30–41. Cichorek M, Wachulska M, Stasiewicz A, Tymińska A. Skin melanocytes: biology and development. Postepy Dermatol Alergol. 2013:30:30–41.
19.
go back to reference Sriram G, Bigliardi PL, Bigliardi-Qi M. Fibroblast heterogeneity and its implications for engineering organotypic skin models in vitro. Eur J Cell Biol. 2015;94:483–512.CrossRefPubMed Sriram G, Bigliardi PL, Bigliardi-Qi M. Fibroblast heterogeneity and its implications for engineering organotypic skin models in vitro. Eur J Cell Biol. 2015;94:483–512.CrossRefPubMed
20.
go back to reference Brohem CA, Cardeal LB, Tiago M, Soengas MS, Barros SB, Maria-Engler SS. Artificial skin in perspective: concepts and applications. Pigment Cell Melanoma Res. 2011;24:35–50.CrossRefPubMed Brohem CA, Cardeal LB, Tiago M, Soengas MS, Barros SB, Maria-Engler SS. Artificial skin in perspective: concepts and applications. Pigment Cell Melanoma Res. 2011;24:35–50.CrossRefPubMed
21.
go back to reference Martel JL, Badri T. Anatomy, Head, Hair, Follicle. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-2018 Jan 10.) Martel JL, Badri T. Anatomy, Head, Hair, Follicle. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-2018 Jan 10.)
23.
go back to reference Ávalos-Díaz E, Herrera Esparza R. Dermatological autoimmune diseases. In: Anaya JM, Shoenfeld Y, Rojas-Villarraga A, Levy RA, Cervera R, editors. Autoimmunity: From Bench to Bedside. Bogota: El Rosario: University Press; 2013. p. 597–610. Ávalos-Díaz E, Herrera Esparza R. Dermatological autoimmune diseases. In: Anaya JM, Shoenfeld Y, Rojas-Villarraga A, Levy RA, Cervera R, editors. Autoimmunity: From Bench to Bedside. Bogota: El Rosario: University Press; 2013. p. 597–610.
25.
go back to reference Bruserud Ø, Oftedal BE, Wolff AB, Husebye ES. AIRE-mutations and autoimmune disease. Curr Opin Immunol. 2016;43:8–15.CrossRefPubMed Bruserud Ø, Oftedal BE, Wolff AB, Husebye ES. AIRE-mutations and autoimmune disease. Curr Opin Immunol. 2016;43:8–15.CrossRefPubMed
26.
27.
28.
go back to reference Obermayer-Straub P, Manns MP. Autoimmune polyglandular syndromes. Baillieres Clin Grastroenterol. 1998;12:293–315.CrossRef Obermayer-Straub P, Manns MP. Autoimmune polyglandular syndromes. Baillieres Clin Grastroenterol. 1998;12:293–315.CrossRef
29.
go back to reference Betterle C, Zanchetta R. Update on autoimmune polymdocrine syndromes (APS). Acta Biomed. 2003;74:9–33.PubMed Betterle C, Zanchetta R. Update on autoimmune polymdocrine syndromes (APS). Acta Biomed. 2003;74:9–33.PubMed
30.
go back to reference Sheehan MT, Islam R. Silent thyroiditis, isolated corticotropin deficiency, and alopecia universalis in a patient with ulcerative colitis and elevated levels of plasma factor VIII: an unusual case of autoimmune polyglandular syndrome type 3. Endocr Pract. 2009;15:138–42.CrossRefPubMed Sheehan MT, Islam R. Silent thyroiditis, isolated corticotropin deficiency, and alopecia universalis in a patient with ulcerative colitis and elevated levels of plasma factor VIII: an unusual case of autoimmune polyglandular syndrome type 3. Endocr Pract. 2009;15:138–42.CrossRefPubMed
31.
go back to reference Di Zenzo G, Della Torre R, Zambruno G, Borradori L. Bullous pemphigoid: from the clinic to the bench. Clin Dermatol. 2012;30:3–16.CrossRefPubMed Di Zenzo G, Della Torre R, Zambruno G, Borradori L. Bullous pemphigoid: from the clinic to the bench. Clin Dermatol. 2012;30:3–16.CrossRefPubMed
32.
go back to reference Cozzani E, Gasparini G, Burlando M, Drago F, Parodi A. Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects. Autoimmun Rev. 2015;14:438–45.CrossRefPubMed Cozzani E, Gasparini G, Burlando M, Drago F, Parodi A. Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects. Autoimmun Rev. 2015;14:438–45.CrossRefPubMed
34.
go back to reference Roujeau J-C, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P. High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol. 1998;134:465–9.CrossRefPubMed Roujeau J-C, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P. High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol. 1998;134:465–9.CrossRefPubMed
35.
go back to reference Colbert RL, Allen DM, Eastwood D, Fairley JA. Mortality rate of bullous pemphigoid in a US Medical Center. J Incest Dermatol. 2004;122:1091–5.CrossRef Colbert RL, Allen DM, Eastwood D, Fairley JA. Mortality rate of bullous pemphigoid in a US Medical Center. J Incest Dermatol. 2004;122:1091–5.CrossRef
36.
go back to reference Jonkman MF, de Jong MC, Heeres K, Pas HH, van der Meer JB, Owaribe K, et al. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest. 1995;95:1345–52. Jonkman MF, de Jong MC, Heeres K, Pas HH, van der Meer JB, Owaribe K, et al. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest. 1995;95:1345–52.
37.
go back to reference Groves RW, Liu L, Dopping-Hepenstal PJ, Markus HS, Lovell PA, Ozoemena L, et al. A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J Invest Dermatol. 2010;130:1551–7. Groves RW, Liu L, Dopping-Hepenstal PJ, Markus HS, Lovell PA, Ozoemena L, et al. A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J Invest Dermatol. 2010;130:1551–7.
38.
go back to reference Büdinger L, Borradori L, Yee C, Eming R, Ferencik S, Grosse-Wilde H, et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest. 1998;102:2082–9. Büdinger L, Borradori L, Yee C, Eming R, Ferencik S, Grosse-Wilde H, et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest. 1998;102:2082–9.
39.
go back to reference Delgado JC, Turbay D, Yunis EJ, Yunis JJ, Morton ED, Bhol K, et al. A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A. 1996;93:8569–71. Delgado JC, Turbay D, Yunis EJ, Yunis JJ, Morton ED, Bhol K, et al. A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A. 1996;93:8569–71.
40.
go back to reference Bastuji-Garin S, Joly P, Picard-Dahan C, Bernard P, Vaillant L, Pauwels C, et al. Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol. 1996;132:272–6. Bastuji-Garin S, Joly P, Picard-Dahan C, Bernard P, Vaillant L, Pauwels C, et al. Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol. 1996;132:272–6.
41.
go back to reference Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Delaporte E, et al. Ingen-Housz-Oro S, Maillard H, Pauwels C, Picard-Dahan C, Dutronc Y, Richard MA; French Study Group for Bullous Diseases. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol. 2011;131:637–43. Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Delaporte E, et al. Ingen-Housz-Oro S, Maillard H, Pauwels C, Picard-Dahan C, Dutronc Y, Richard MA; French Study Group for Bullous Diseases. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol. 2011;131:637–43.
42.
go back to reference Ljubojevic S, Lipozenčić J. Autoimmune bullous diseases associations. Clin Dermatol. 2012;30:17–33.CrossRefPubMed Ljubojevic S, Lipozenčić J. Autoimmune bullous diseases associations. Clin Dermatol. 2012;30:17–33.CrossRefPubMed
43.
go back to reference Callen JP, McCall MW. Bullous pemphigoid and Hashimoto’s thyroiditis. J am Acad Dermatol. 1981;5:558–60.CrossRefPubMed Callen JP, McCall MW. Bullous pemphigoid and Hashimoto’s thyroiditis. J am Acad Dermatol. 1981;5:558–60.CrossRefPubMed
44.
go back to reference Fiorucci MC, Cozzani E, Casu M, Murialdo G, Parodi A, Rebora A. Bullous pemphigoid and Graves' disease: an association between skin and thyroid autoimmunity. Acta Derm Venereol. 2005;85:560–1.PubMed Fiorucci MC, Cozzani E, Casu M, Murialdo G, Parodi A, Rebora A. Bullous pemphigoid and Graves' disease: an association between skin and thyroid autoimmunity. Acta Derm Venereol. 2005;85:560–1.PubMed
45.
go back to reference How J, Bewsher PD, Stankler L. Bullous pemphigoid, polymyalgia rheumatica and thyroid disease. Br J Dermatol. 1980;103:201–4.CrossRefPubMed How J, Bewsher PD, Stankler L. Bullous pemphigoid, polymyalgia rheumatica and thyroid disease. Br J Dermatol. 1980;103:201–4.CrossRefPubMed
46.
go back to reference Ameri P, Cinotti E, Mussap M, Murialdo G, Parodi A, Cozzani E. Association of pemphigus and bullous pemphigoid with thyroid autoimmunity in Caucasian patients. J Am Acad Dermatol. 2013;68:687–9.CrossRefPubMed Ameri P, Cinotti E, Mussap M, Murialdo G, Parodi A, Cozzani E. Association of pemphigus and bullous pemphigoid with thyroid autoimmunity in Caucasian patients. J Am Acad Dermatol. 2013;68:687–9.CrossRefPubMed
48.
go back to reference Schmidt E, Höpfner B, Chen M, Kuhn C, Weber L, Bröcker EB, et al. Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. Br J Dermatol. 2002;147:592–7. Schmidt E, Höpfner B, Chen M, Kuhn C, Weber L, Bröcker EB, et al. Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. Br J Dermatol. 2002;147:592–7.
49.
go back to reference Chen M, Kim GH, Prakash L, Woodley DT. Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen. Autoimmunity. 2012;45:91–101.CrossRefPubMed Chen M, Kim GH, Prakash L, Woodley DT. Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen. Autoimmunity. 2012;45:91–101.CrossRefPubMed
50.
go back to reference Roenigk HH, Ryan JG, Bergfeld WF. Epidermolysis bullosa acquisita: Report of three cases and review of all published cases. Arch Dermatol. 1971;103(1):10.CrossRef Roenigk HH, Ryan JG, Bergfeld WF. Epidermolysis bullosa acquisita: Report of three cases and review of all published cases. Arch Dermatol. 1971;103(1):10.CrossRef
51.
go back to reference Chen M, O'Toole EA, Sanghavi J, Mahmud N, Kelleher D. Type VII collagen exists in human intestine and serves as an antigenic target in patients with inflammatory bowel disease. J Invest Dermatol. 1997;108:542. Chen M, O'Toole EA, Sanghavi J, Mahmud N, Kelleher D. Type VII collagen exists in human intestine and serves as an antigenic target in patients with inflammatory bowel disease. J Invest Dermatol. 1997;108:542.
52.
go back to reference Oostingh GJ, Sitaru C, Zillikens D, Kromminga A, Lührs H, Kromminga A, et al. Subclass distribution of type VII collagen-specific autoantibodies in patients with inflammatory bowel disease. J Dermatol Sci. 2005;37:182–4. Oostingh GJ, Sitaru C, Zillikens D, Kromminga A, Lührs H, Kromminga A, et al. Subclass distribution of type VII collagen-specific autoantibodies in patients with inflammatory bowel disease. J Dermatol Sci. 2005;37:182–4.
53.
go back to reference Kakar R, Paugh H, Jaworsky C. Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature. Dermatology. 2013;227:209–13.CrossRefPubMed Kakar R, Paugh H, Jaworsky C. Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature. Dermatology. 2013;227:209–13.CrossRefPubMed
54.
go back to reference Zenke Y, Nakano T, Eto H, Koga H, Hashimoto T. A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the a3 subunit of laminin-332. Br J Dermatol. 2014;170:965–9.CrossRefPubMed Zenke Y, Nakano T, Eto H, Koga H, Hashimoto T. A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the a3 subunit of laminin-332. Br J Dermatol. 2014;170:965–9.CrossRefPubMed
55.
go back to reference Tashima S, Konishi K, Koga H, Hashimoto T. A case of vancomycin-induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180. Int J Dermatol. 2014;53:e207–9.CrossRefPubMed Tashima S, Konishi K, Koga H, Hashimoto T. A case of vancomycin-induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180. Int J Dermatol. 2014;53:e207–9.CrossRefPubMed
57.
go back to reference Mobacken H, Kastrup W, Ljunghall K, Löfberg H, Nilsson LA, Svensson A, et al. Linear IgA dermatosis: a study of ten adult patients. Acta Derm Venereol. 1983;63:123–8. Mobacken H, Kastrup W, Ljunghall K, Löfberg H, Nilsson LA, Svensson A, et al. Linear IgA dermatosis: a study of ten adult patients. Acta Derm Venereol. 1983;63:123–8.
58.
go back to reference Klein PA, Callen JP. Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency. J Am Acad Dermatol. 2000;42:316–23.CrossRefPubMed Klein PA, Callen JP. Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency. J Am Acad Dermatol. 2000;42:316–23.CrossRefPubMed
59.
go back to reference Pereira AR, Moura LH, Pinheiro JR, Pasin VP, Enokihara MM, Porro AM. Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis. An Bras Dermatol. 2016;91:35–8.CrossRefPubMedPubMedCentral Pereira AR, Moura LH, Pinheiro JR, Pasin VP, Enokihara MM, Porro AM. Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis. An Bras Dermatol. 2016;91:35–8.CrossRefPubMedPubMedCentral
60.
go back to reference Porter WM, Hardman CM, Leonard JN, Fry L. Sarcoidosis in a patient with linear IgA disease. Clin Exp Dermatol. 1999;24:67–70.CrossRefPubMed Porter WM, Hardman CM, Leonard JN, Fry L. Sarcoidosis in a patient with linear IgA disease. Clin Exp Dermatol. 1999;24:67–70.CrossRefPubMed
61.
go back to reference Yang JY, Park I, Kim SK. Concurrent Linear Immunoglobulin A Dermatosis, Hashimoto Thyroiditis, and Immunoglobulin A Nephropathy in an Adult. Ann Dermatol. 2017;29:226–8.CrossRefPubMedPubMedCentral Yang JY, Park I, Kim SK. Concurrent Linear Immunoglobulin A Dermatosis, Hashimoto Thyroiditis, and Immunoglobulin A Nephropathy in an Adult. Ann Dermatol. 2017;29:226–8.CrossRefPubMedPubMedCentral
62.
go back to reference Fry L, Keir P, McMinn RM, Cowan JD, Hoffbrand AV. Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet. 1967;2:729–33.CrossRefPubMed Fry L, Keir P, McMinn RM, Cowan JD, Hoffbrand AV. Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet. 1967;2:729–33.CrossRefPubMed
63.
go back to reference Reunala T, Salmi TT, Hervonen K. Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet. Acta Derm Venereol. 2015;95:917–22.CrossRefPubMed Reunala T, Salmi TT, Hervonen K. Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet. Acta Derm Venereol. 2015;95:917–22.CrossRefPubMed
64.
go back to reference Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol. 1997;136:315–8.CrossRefPubMed Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol. 1997;136:315–8.CrossRefPubMed
65.
go back to reference Kaplan RP, Callen JP. Dermatitis herpetiformis: autoimmune disease associations. Clin Dermatol. 1991;9:347–60.CrossRefPubMed Kaplan RP, Callen JP. Dermatitis herpetiformis: autoimmune disease associations. Clin Dermatol. 1991;9:347–60.CrossRefPubMed
66.
go back to reference Zettinig G, Weissel M, Flores J, Dudczak R, Vogelsang H. Dermatitis herpetiformis is associated with atrophic but not with goitrous variant of Hashimoto's thyroiditis. Eur J Clin Invest. 2000;30:53–7.CrossRefPubMed Zettinig G, Weissel M, Flores J, Dudczak R, Vogelsang H. Dermatitis herpetiformis is associated with atrophic but not with goitrous variant of Hashimoto's thyroiditis. Eur J Clin Invest. 2000;30:53–7.CrossRefPubMed
67.
go back to reference Stanley JR, Amagai M. Autoimmune bullous diseases: historical prospective. J Invest Dermatol. 2008;128:E16–8.CrossRefPubMed Stanley JR, Amagai M. Autoimmune bullous diseases: historical prospective. J Invest Dermatol. 2008;128:E16–8.CrossRefPubMed
68.
go back to reference Anhalth GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. New Engl J Med. 1982;306:1189–96.CrossRef Anhalth GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. New Engl J Med. 1982;306:1189–96.CrossRef
69.
go back to reference Zakka LR, Keskin DB, Reche P, Ahmed AR. Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously. Clin Exp Immunol. 2010;162:224–36.CrossRefPubMedPubMedCentral Zakka LR, Keskin DB, Reche P, Ahmed AR. Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously. Clin Exp Immunol. 2010;162:224–36.CrossRefPubMedPubMedCentral
70.
go back to reference De Stefano GM, Christano AM. The genetics of human skin disease. Cold Spring Harb Perspect Med. 2014;4:a015172.CrossRef De Stefano GM, Christano AM. The genetics of human skin disease. Cold Spring Harb Perspect Med. 2014;4:a015172.CrossRef
71.
go back to reference Nancy AL, Yehuda S. Prediction and prevention of autoimmune skin disorders. Arch Dermatol Res. 2009;301:57–64.CrossRefPubMed Nancy AL, Yehuda S. Prediction and prevention of autoimmune skin disorders. Arch Dermatol Res. 2009;301:57–64.CrossRefPubMed
72.
go back to reference Callen JP. Internal disorders associated with bullous disease of the skin. A critical review. J Am Acad Dermatol. 1980;3:107–19.CrossRefPubMed Callen JP. Internal disorders associated with bullous disease of the skin. A critical review. J Am Acad Dermatol. 1980;3:107–19.CrossRefPubMed
73.
go back to reference Heelan K, Mahar AL, Walsh S, Shear NH. Pemphigus and associated comorbidities: a cross-sectional study. Clin Exp Dermatol. 2015;40:593–9.CrossRefPubMed Heelan K, Mahar AL, Walsh S, Shear NH. Pemphigus and associated comorbidities: a cross-sectional study. Clin Exp Dermatol. 2015;40:593–9.CrossRefPubMed
74.
go back to reference Leshem YA, Katzenelson V, Yosipovitich G, Mimouni D. Autoimmune diseases in patients with pemphigus and their first-degree relatives. Int J Dermatol. 2011;50:827–31.CrossRefPubMed Leshem YA, Katzenelson V, Yosipovitich G, Mimouni D. Autoimmune diseases in patients with pemphigus and their first-degree relatives. Int J Dermatol. 2011;50:827–31.CrossRefPubMed
75.
go back to reference Kavala M, Kural E, Kocaturk E, Zindanci I, Turkoglu Z, Can B. The evaluation of thyroid diseases in patients with pemphigus vulgaris. Scientific World Journal. 2012;2012:146897.CrossRefPubMed Kavala M, Kural E, Kocaturk E, Zindanci I, Turkoglu Z, Can B. The evaluation of thyroid diseases in patients with pemphigus vulgaris. Scientific World Journal. 2012;2012:146897.CrossRefPubMed
76.
go back to reference Ansar A, Farshchian M, Farahnaki S, Farshchian M. Thyroid autoimmunity in Iranian patients with pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2009;23:719–20.CrossRefPubMed Ansar A, Farshchian M, Farahnaki S, Farshchian M. Thyroid autoimmunity in Iranian patients with pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2009;23:719–20.CrossRefPubMed
77.
go back to reference Pitoia F, Moncet D, Glorio R, Graciela Diaz A, Rodriguez Costa G, Carbia S, et al. Prevalence of thyroid autoimmunity in patients with pemphigus vulgaris. Medicina (B Aires). 2005;65:307–10.PubMed Pitoia F, Moncet D, Glorio R, Graciela Diaz A, Rodriguez Costa G, Carbia S, et al. Prevalence of thyroid autoimmunity in patients with pemphigus vulgaris. Medicina (B Aires). 2005;65:307–10.PubMed
78.
go back to reference Daneshpazhooh M, Behjati J, Hashemi P, Shamohammadi S, Mortazavi H, Nazemi MJ, et al. Thyroid autoimmunity and pemphigus vulgaris: is there a significant association? J Am Acad Dermatol. 2010;62:349–51. Daneshpazhooh M, Behjati J, Hashemi P, Shamohammadi S, Mortazavi H, Nazemi MJ, et al. Thyroid autoimmunity and pemphigus vulgaris: is there a significant association? J Am Acad Dermatol. 2010;62:349–51.
79.
go back to reference Nisihara RM, de Bem RS, Hausberger R, Roxo VS, Pavoni DP, Petzl-Erler ML, et al. Prevalence of autoantibodies in patients with endemic pemphigus foliaceus (fogo selvagem). Arch Dermatol Res. 2003;295:133–7. Nisihara RM, de Bem RS, Hausberger R, Roxo VS, Pavoni DP, Petzl-Erler ML, et al. Prevalence of autoantibodies in patients with endemic pemphigus foliaceus (fogo selvagem). Arch Dermatol Res. 2003;295:133–7.
80.
go back to reference Baldini E, Odorisio T, Sorrenti S, Catania A, Tartaglia F, Carbotta G, et al. Vitiligo and autoimmune thyroid disorders. Front Endocrinol (Lausanne). 2017;8:290. Baldini E, Odorisio T, Sorrenti S, Catania A, Tartaglia F, Carbotta G, et al. Vitiligo and autoimmune thyroid disorders. Front Endocrinol (Lausanne). 2017;8:290.
81.
go back to reference Kim YC, Kim YJ, Kang HY, Sohn S, Lee ES. Histopathologic features in vitiligo. Am J Dermatopathol. 2008;30:112–6.CrossRefPubMed Kim YC, Kim YJ, Kang HY, Sohn S, Lee ES. Histopathologic features in vitiligo. Am J Dermatopathol. 2008;30:112–6.CrossRefPubMed
82.
go back to reference Ferrari SM, Fallahi P, Santaguida G, Virili C, Ruffilli I, Ragusa F, et al. Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis. Autoimmun Rev. 2017;16:946–50. Ferrari SM, Fallahi P, Santaguida G, Virili C, Ruffilli I, Ragusa F, et al. Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis. Autoimmun Rev. 2017;16:946–50.
83.
go back to reference Antonelli A, Ferrari SM, Fallahi P. The role of the Th1 chemokine CXCL10 in vitiligo. Ann Transl Med. 2015;3(Suppl 1):S16.PubMedPubMedCentral Antonelli A, Ferrari SM, Fallahi P. The role of the Th1 chemokine CXCL10 in vitiligo. Ann Transl Med. 2015;3(Suppl 1):S16.PubMedPubMedCentral
84.
go back to reference Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, et al. Vitiligo global issue consensus conference panelists. Pigment Cell Melanoma Res. 2012;25:E1–13. Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, et al. Vitiligo global issue consensus conference panelists. Pigment Cell Melanoma Res. 2012;25:E1–13.
85.
go back to reference Pandve HT. Vitiligo. is it just a dermatological disorder? Indian J Dermatol. 2008;53:40–1. Pandve HT. Vitiligo. is it just a dermatological disorder? Indian J Dermatol. 2008;53:40–1.
86.
go back to reference Lai Y, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2016;177:708–18.CrossRef Lai Y, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2016;177:708–18.CrossRef
87.
go back to reference Patel S, Rauf A, Khan H, Meher BR, ul Hassan SS. A holistic review on the autoimmune disease vitiligo with emphasis on the casual factors. Biomed Pharmacother. 2017;92:501–8.CrossRefPubMed Patel S, Rauf A, Khan H, Meher BR, ul Hassan SS. A holistic review on the autoimmune disease vitiligo with emphasis on the casual factors. Biomed Pharmacother. 2017;92:501–8.CrossRefPubMed
89.
90.
go back to reference Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. Vitiligo Working Group. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017;77:1–13.CrossRefPubMed Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. Vitiligo Working Group. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017;77:1–13.CrossRefPubMed
91.
92.
go back to reference Jin Y, Ferrara T, Gowan K, Holcomb C, Rastrou M, Erlich HA, et al. Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation. J Invest Dermatol. 2012;132:1730–3. Jin Y, Ferrara T, Gowan K, Holcomb C, Rastrou M, Erlich HA, et al. Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation. J Invest Dermatol. 2012;132:1730–3.
93.
go back to reference Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol. 2007;21:921–8.CrossRefPubMed Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol. 2007;21:921–8.CrossRefPubMed
94.
go back to reference Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigement Cell Melanoma Res. 2003;16:208–14.CrossRef Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigement Cell Melanoma Res. 2003;16:208–14.CrossRef
95.
go back to reference Cunliffe WJ, Hall R, Newell DJ, Stevenson CJ. Vitiligo, thyroid disease and autoimmunity. Br J Dermatol. 1968;80:135–9.CrossRefPubMed Cunliffe WJ, Hall R, Newell DJ, Stevenson CJ. Vitiligo, thyroid disease and autoimmunity. Br J Dermatol. 1968;80:135–9.CrossRefPubMed
96.
go back to reference Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I. Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study. J Am Acad Dermatol. 2016;74:295–302.CrossRefPubMed Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I. Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study. J Am Acad Dermatol. 2016;74:295–302.CrossRefPubMed
97.
go back to reference Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 2005;18:300–5. Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 2005;18:300–5.
98.
go back to reference Sheth VM, Guo Y, Qureshi AA. Comorbidities associated with vitiligo: a ten-year retrospective study. Dermatology. 2013;227:311–5.CrossRefPubMed Sheth VM, Guo Y, Qureshi AA. Comorbidities associated with vitiligo: a ten-year retrospective study. Dermatology. 2013;227:311–5.CrossRefPubMed
99.
go back to reference Amerio P, Di Rollo D, Carbone A, Auriemma M, Marra ME, De Remigis P, et al. Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases. Eur J Dermatol. 2010;20:354–8. Amerio P, Di Rollo D, Carbone A, Auriemma M, Marra ME, De Remigis P, et al. Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases. Eur J Dermatol. 2010;20:354–8.
100.
go back to reference Narita T, Oiso N, Fukai K, Kabashima K, Kawada A, Suzuki T. Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families. Allergol Int. 2011;60:505–8.CrossRefPubMed Narita T, Oiso N, Fukai K, Kabashima K, Kawada A, Suzuki T. Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families. Allergol Int. 2011;60:505–8.CrossRefPubMed
101.
go back to reference Fallahi P, Ferrari SM, Ruffilli I, Elia G, Biricotti M, Vita R, et al. The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients. Autoimmun Rev. 2016;15:1125–8. Fallahi P, Ferrari SM, Ruffilli I, Elia G, Biricotti M, Vita R, et al. The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients. Autoimmun Rev. 2016;15:1125–8.
102.
go back to reference Ruggeri RM, Trimarchi F, Giuffrida G, Certo R, Cama E, Campennì A, et al. Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence. Eur J Endocrinol. 2017;176:133–41. Ruggeri RM, Trimarchi F, Giuffrida G, Certo R, Cama E, Campennì A, et al. Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence. Eur J Endocrinol. 2017;176:133–41.
103.
go back to reference Saylam Kurtipek G, Cihan FG, Erayman Demirbaş Ş, Ataseven A. The Frequency of autoimmune thyroid disease in alopecia areata and vitiligo patients. Biomed Res Int. 2015;2015:435947.CrossRefPubMedPubMedCentral Saylam Kurtipek G, Cihan FG, Erayman Demirbaş Ş, Ataseven A. The Frequency of autoimmune thyroid disease in alopecia areata and vitiligo patients. Biomed Res Int. 2015;2015:435947.CrossRefPubMedPubMedCentral
104.
go back to reference Nejad SB, Qadim HH, Nazeman L, Fadaii R, Goldust M. Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population. Pak J Biol Sci. 2013;16:570–4.CrossRefPubMed Nejad SB, Qadim HH, Nazeman L, Fadaii R, Goldust M. Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population. Pak J Biol Sci. 2013;16:570–4.CrossRefPubMed
105.
go back to reference Colucci R, Lotti F, Dragoni F, Arunachalam M, Lotti T, Benvenga S, et al. High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients. Br J Dermatol. 2014;171:786–98. Colucci R, Lotti F, Dragoni F, Arunachalam M, Lotti T, Benvenga S, et al. High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients. Br J Dermatol. 2014;171:786–98.
106.
go back to reference Lazzeri L, Colucci R, Cammi A, Dragoni F, Moretti S. Adult onset vitiligo: multivariate analysis suggests the need for a thyroid screening. Biomed Res Int. 2016;2016:8065765.CrossRefPubMedPubMedCentral Lazzeri L, Colucci R, Cammi A, Dragoni F, Moretti S. Adult onset vitiligo: multivariate analysis suggests the need for a thyroid screening. Biomed Res Int. 2016;2016:8065765.CrossRefPubMedPubMedCentral
107.
go back to reference Bae JM, Lee JH, Yun JS, Han B, Han TY. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea. J Am Acad Dermatol. 2017;76:871–8.CrossRefPubMed Bae JM, Lee JH, Yun JS, Han B, Han TY. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea. J Am Acad Dermatol. 2017;76:871–8.CrossRefPubMed
108.
109.
go back to reference Vrijman C, Kroon MW, Limpens J, Leeflang MM, Luiten RM, van der Veen JP, et al. The prevalence of thyroid disease in patients with vitiligo: a systematic review. Br J Dermatol. 2012;167:1224–35. Vrijman C, Kroon MW, Limpens J, Leeflang MM, Luiten RM, van der Veen JP, et al. The prevalence of thyroid disease in patients with vitiligo: a systematic review. Br J Dermatol. 2012;167:1224–35.
110.
go back to reference Colucci R, Lotti F, Arunachalam M, Lotti T, Dragoni F, Benvenga S, et al. Correlation of serum thyroid hormones autoantibodies with self-reported exposure to thyroid disruptors in a group of nonsegmental vitiligo patients. Arch Environ Contam Toxicol. 2015;69:181–90. Colucci R, Lotti F, Arunachalam M, Lotti T, Dragoni F, Benvenga S, et al. Correlation of serum thyroid hormones autoantibodies with self-reported exposure to thyroid disruptors in a group of nonsegmental vitiligo patients. Arch Environ Contam Toxicol. 2015;69:181–90.
111.
go back to reference Shong YK, Kim JA. Vitiligo in autoimmune thyroid disease. Thyroidology. 1991;3:89–91.PubMed Shong YK, Kim JA. Vitiligo in autoimmune thyroid disease. Thyroidology. 1991;3:89–91.PubMed
112.
go back to reference Artantaş S, Gül U, Kiliç A, Güler S. Skin findings in thyroid diseases. Eur J Intern Med. 2009;20:158–61.CrossRefPubMed Artantaş S, Gül U, Kiliç A, Güler S. Skin findings in thyroid diseases. Eur J Intern Med. 2009;20:158–61.CrossRefPubMed
113.
go back to reference Vita R, Santaguida MG, Virili C, Segni M, Galletti M, Mandolfino M, et al. Serum thyroid hormone antibodies are frequent in patients with polyglandular autoimmune syndrome type 3, particularly in those who require thyroxine treatment. Front Endocrinol. 2017;8:212. Vita R, Santaguida MG, Virili C, Segni M, Galletti M, Mandolfino M, et al. Serum thyroid hormone antibodies are frequent in patients with polyglandular autoimmune syndrome type 3, particularly in those who require thyroxine treatment. Front Endocrinol. 2017;8:212.
114.
115.
go back to reference Powell RJ, Du Toit GL, Siddique N, Leech SC, Dixon TA, Clark AT, et al. British Society for Allergy and Clinical Immunology (BSACI). BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy. 2007;37(5):631–50. Powell RJ, Du Toit GL, Siddique N, Leech SC, Dixon TA, Clark AT, et al. British Society for Allergy and Clinical Immunology (BSACI). BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy. 2007;37(5):631–50.
116.
go back to reference Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64:1256–68.CrossRefPubMed Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64:1256–68.CrossRefPubMed
117.
go back to reference Tedeschi A, Cottini M, Asero R. Simultaneous occurrence of chronic autoimmune urticaria and non-allergic asthma: a common mechanism? Eur Ann Allergy Clin Immunol. 2009;41:56–9.PubMed Tedeschi A, Cottini M, Asero R. Simultaneous occurrence of chronic autoimmune urticaria and non-allergic asthma: a common mechanism? Eur Ann Allergy Clin Immunol. 2009;41:56–9.PubMed
118.
go back to reference Confino-Cohen R, Chodick G, Shalev V, Leshno M, Kimhi O, Goldberg A. Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol. 2012;129:1307–13.CrossRefPubMed Confino-Cohen R, Chodick G, Shalev V, Leshno M, Kimhi O, Goldberg A. Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol. 2012;129:1307–13.CrossRefPubMed
119.
120.
go back to reference Kolkhir P, Borzova E, Grattan C, Asero R, Pogorelov D, Maurer M. Autoimmune comorbidity in chronic spontaneous urticaria: A systematic review. Autoimmun Rev. 2017;16:1196–208.CrossRefPubMed Kolkhir P, Borzova E, Grattan C, Asero R, Pogorelov D, Maurer M. Autoimmune comorbidity in chronic spontaneous urticaria: A systematic review. Autoimmun Rev. 2017;16:1196–208.CrossRefPubMed
121.
go back to reference Rottem M. Chronic urticaria and autoimmune thyroid disease: is there a link? Autoimmun Rev. 2003;2:69–72.CrossRefPubMed Rottem M. Chronic urticaria and autoimmune thyroid disease: is there a link? Autoimmun Rev. 2003;2:69–72.CrossRefPubMed
122.
go back to reference Bagnasco M, Minciullo PL, Saraceno GS, Gangemi S, Benvenga S. Urticaria and thyroid autoimmunity. Thyroid. 2011;21:401–10.CrossRefPubMed Bagnasco M, Minciullo PL, Saraceno GS, Gangemi S, Benvenga S. Urticaria and thyroid autoimmunity. Thyroid. 2011;21:401–10.CrossRefPubMed
123.
go back to reference Dreskin SC, Andrews KY. The thyroid and urticaria. Curr Opin Allergy Clin Immunol. 2005;5:408–12.CrossRefPubMed Dreskin SC, Andrews KY. The thyroid and urticaria. Curr Opin Allergy Clin Immunol. 2005;5:408–12.CrossRefPubMed
124.
go back to reference Kolkhir P, Metz M, AltricHashimoto thyroiditiser S, Maurer M. Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: A systematic review. Allergy. 2017;72:1440–60.CrossRefPubMed Kolkhir P, Metz M, AltricHashimoto thyroiditiser S, Maurer M. Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: A systematic review. Allergy. 2017;72:1440–60.CrossRefPubMed
125.
go back to reference O'Donnell BF, Francis DM, Swana GT, Seed PT, Kobza Black A, Greaves MW. Thyroid autoimmunity in chronic urticaria. Br J Dermatol. 2005;153:331–5.CrossRefPubMed O'Donnell BF, Francis DM, Swana GT, Seed PT, Kobza Black A, Greaves MW. Thyroid autoimmunity in chronic urticaria. Br J Dermatol. 2005;153:331–5.CrossRefPubMed
126.
go back to reference Ruggeri RM, Imbesi S, Saitta S, Campennì A, Cannavò S, Trimarchi F, et al. Chronic idiopathic urticaria and Graves' disease. J Endocrinol Invest. 2013;36:531–6. Ruggeri RM, Imbesi S, Saitta S, Campennì A, Cannavò S, Trimarchi F, et al. Chronic idiopathic urticaria and Graves' disease. J Endocrinol Invest. 2013;36:531–6.
127.
go back to reference Lanigan SW, Short P, Moult P. The association of chronic urticaria and thyroid autoimmunity. Clin Exp Dermatol. 1987;12:335–8.CrossRefPubMed Lanigan SW, Short P, Moult P. The association of chronic urticaria and thyroid autoimmunity. Clin Exp Dermatol. 1987;12:335–8.CrossRefPubMed
128.
go back to reference Hordinsky MK. Overview of alopecia areata. J Invest Dermatol. 2013;16:S13–5.CrossRef Hordinsky MK. Overview of alopecia areata. J Invest Dermatol. 2013;16:S13–5.CrossRef
129.
go back to reference Spano F, Donovan JC. Alopecia areata. Part 1:pathogenesis, diagnosis, and prognosis. Can Fam Physician. 2015;61:751–5.PubMedPubMedCentral Spano F, Donovan JC. Alopecia areata. Part 1:pathogenesis, diagnosis, and prognosis. Can Fam Physician. 2015;61:751–5.PubMedPubMedCentral
130.
go back to reference Bodemer C, Peuchmaur M, Fraitaig S, Chatenoud L, Brousse N, De Prost Y. Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol. 2000;114:112–6.CrossRefPubMed Bodemer C, Peuchmaur M, Fraitaig S, Chatenoud L, Brousse N, De Prost Y. Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol. 2000;114:112–6.CrossRefPubMed
132.
go back to reference Bertolini M, Zilio F, Rossi A, Kleditzsch P, Emelianov VE, Gilhar A, et al. Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata. PLoS One. 2014;9:e94260. Bertolini M, Zilio F, Rossi A, Kleditzsch P, Emelianov VE, Gilhar A, et al. Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata. PLoS One. 2014;9:e94260.
133.
go back to reference Wang EH, Yu M, Breitkopf T, Akhoundsadegh N, Wang X, Shi FT, et al. Identification of autoantigen epitopes in alopecia areata. J Invest Dermatol. 2016;136:1617–26.CrossRefPubMed Wang EH, Yu M, Breitkopf T, Akhoundsadegh N, Wang X, Shi FT, et al. Identification of autoantigen epitopes in alopecia areata. J Invest Dermatol. 2016;136:1617–26.CrossRefPubMed
134.
go back to reference Bertolini M, Rossi A, Paus R. Cover Image: Are melanocyte-associated peptides the elusive autoantigens in alopecia areata? Br J Dermatol. 2017;176:1106.CrossRefPubMed Bertolini M, Rossi A, Paus R. Cover Image: Are melanocyte-associated peptides the elusive autoantigens in alopecia areata? Br J Dermatol. 2017;176:1106.CrossRefPubMed
135.
go back to reference Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015 Feb;14(2):81–9.CrossRefPubMed Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015 Feb;14(2):81–9.CrossRefPubMed
137.
go back to reference Patel D, Li P, Bauer AJ, Castelo-Soccio C. Screening guidelines for thyroid function in children with alopecia areata. JAMA Dermatol. 2017;153:1307–10.CrossRefPubMedPubMedCentral Patel D, Li P, Bauer AJ, Castelo-Soccio C. Screening guidelines for thyroid function in children with alopecia areata. JAMA Dermatol. 2017;153:1307–10.CrossRefPubMedPubMedCentral
138.
go back to reference Huang KP, Mullangi S, Guo Y, Qureshi AA. Autoimmune, atopic, and mental health comorbidity conditions associated with alopecia areata in the United Stayes. JAMA Dermatol. 2013;149:789–94.CrossRefPubMed Huang KP, Mullangi S, Guo Y, Qureshi AA. Autoimmune, atopic, and mental health comorbidity conditions associated with alopecia areata in the United Stayes. JAMA Dermatol. 2013;149:789–94.CrossRefPubMed
139.
go back to reference Baars MP, Greebe RJ, Pop VJM. High prevalence of thyroid peroxidase antibodies in patients with alopecia areata. J Eur Acad Dermatol Venereol. 2013;27:e136-47.CrossRef Baars MP, Greebe RJ, Pop VJM. High prevalence of thyroid peroxidase antibodies in patients with alopecia areata. J Eur Acad Dermatol Venereol. 2013;27:e136-47.CrossRef
140.
go back to reference Conic RZ, Miller R, Piliang M, Bergfeld W, Mesinkovska NA. Comorbidities in patients with alopecia areata. J Am Acad Dermatol. 2017;76:755–7.CrossRefPubMed Conic RZ, Miller R, Piliang M, Bergfeld W, Mesinkovska NA. Comorbidities in patients with alopecia areata. J Am Acad Dermatol. 2017;76:755–7.CrossRefPubMed
141.
go back to reference Bin Saif GA. Severe subtype of alopecia areata is highly associated with thyroid autoimmunity. Saudi Med J. 2016;37:656–61.CrossRefPubMed Bin Saif GA. Severe subtype of alopecia areata is highly associated with thyroid autoimmunity. Saudi Med J. 2016;37:656–61.CrossRefPubMed
143.
go back to reference Guran T, Bircan R, Turan S, Bereket A. Alopecia: association with resistance to thyroid hormone. J Pediatr Endocrinol Metab. 2009;22:1075–81.PubMed Guran T, Bircan R, Turan S, Bereket A. Alopecia: association with resistance to thyroid hormone. J Pediatr Endocrinol Metab. 2009;22:1075–81.PubMed
144.
go back to reference Maatough A, Whitfield GK, Brook L, Hsieh D, Palade P, Hsieh JC. Human Hairless Protein Roles in Skin/Hair and Emerging Connections to Brain and Other Cancers. J Cell Biochem. 2018;119:69–80.CrossRefPubMed Maatough A, Whitfield GK, Brook L, Hsieh D, Palade P, Hsieh JC. Human Hairless Protein Roles in Skin/Hair and Emerging Connections to Brain and Other Cancers. J Cell Biochem. 2018;119:69–80.CrossRefPubMed
145.
go back to reference Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133:377–85.CrossRefPubMed Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133:377–85.CrossRefPubMed
146.
go back to reference Karczewski J, Dobrowolska A, Rychlewska-Hańczewska A, Adamski Z. New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis. Autoimmunity. 2016;49:435–50.CrossRefPubMed Karczewski J, Dobrowolska A, Rychlewska-Hańczewska A, Adamski Z. New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis. Autoimmunity. 2016;49:435–50.CrossRefPubMed
147.
go back to reference Alwan W, Nestle FO. Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S2–6.PubMed Alwan W, Nestle FO. Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S2–6.PubMed
148.
go back to reference Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148:1–18.CrossRefPubMed Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148:1–18.CrossRefPubMed
149.
go back to reference Schmitt-Egenolf M, Eiermann TH, Boehncke WH, Ständer M, Sterry W. Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based study. J Invest Dermatol. 1996;106:711–4.CrossRefPubMed Schmitt-Egenolf M, Eiermann TH, Boehncke WH, Ständer M, Sterry W. Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based study. J Invest Dermatol. 1996;106:711–4.CrossRefPubMed
151.
go back to reference Tsoi LC, Spain SL, Ellinghaus E, Stuart PE, Capon F, Knig J, et al. Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci. Nat Commun. 2015;6:7001. Tsoi LC, Spain SL, Ellinghaus E, Stuart PE, Capon F, Knig J, et al. Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci. Nat Commun. 2015;6:7001.
152.
go back to reference Yin X, Low HQ, Wang L, Li Y, Ellinghaus E, Han J, et al. Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility. Nat Commun. 2015;6:6916. Yin X, Low HQ, Wang L, Li Y, Ellinghaus E, Han J, et al. Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility. Nat Commun. 2015;6:6916.
153.
go back to reference Khan SR, Bano A, Wakkee M, Korevaar TIM, Franco OH, Nijsten TEC, et al. The association of autoimmune thyroid disease (AITD) with psoriatic disease: a prospective cohort study, systematic review and meta-analysis. Eur J Endocrinol. 2017;177:347–59. Khan SR, Bano A, Wakkee M, Korevaar TIM, Franco OH, Nijsten TEC, et al. The association of autoimmune thyroid disease (AITD) with psoriatic disease: a prospective cohort study, systematic review and meta-analysis. Eur J Endocrinol. 2017;177:347–59.
154.
go back to reference Wu JJ, Nguyen TU, Poon KY, Herrinton LJ. The association of psoriasis with autoimmune diseases. J Am Acad Dermatol. 2012;67:924–30.CrossRefPubMed Wu JJ, Nguyen TU, Poon KY, Herrinton LJ. The association of psoriasis with autoimmune diseases. J Am Acad Dermatol. 2012;67:924–30.CrossRefPubMed
155.
go back to reference Antonelli A, Delle Sedie A, Fallahi P, Ferrari SM, Maccheroni M, Ferrannini E, et al. High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis. J Rheumatol. 2006;33:2026–8. Antonelli A, Delle Sedie A, Fallahi P, Ferrari SM, Maccheroni M, Ferrannini E, et al. High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis. J Rheumatol. 2006;33:2026–8.
156.
go back to reference Peluso R, Lupoli GA, Del Puente A, Iervolino S, Bruner V, Lupoli R, et al. Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. J Rheumatol. 2011;38:1371–7. Peluso R, Lupoli GA, Del Puente A, Iervolino S, Bruner V, Lupoli R, et al. Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. J Rheumatol. 2011;38:1371–7.
157.
go back to reference Tsai TF, Wang TS, Hung ST, Tsai PI, Schenkel B, Zhang M, et al. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci. 2011;63:40–6. Tsai TF, Wang TS, Hung ST, Tsai PI, Schenkel B, Zhang M, et al. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci. 2011;63:40–6.
158.
go back to reference Arakawa A, Siewert K, Stöhr J, Besgen P, Kim SM, Rühl G, et al. Melanocyte antigen triggers autoimmunity in human psoriasis. J Exp Med. 2015;212:2203–12. Arakawa A, Siewert K, Stöhr J, Besgen P, Kim SM, Rühl G, et al. Melanocyte antigen triggers autoimmunity in human psoriasis. J Exp Med. 2015;212:2203–12.
159.
161.
go back to reference Simmonds MJ. GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis. Nat Rev Endocrinol. 2013;9:277–87.CrossRefPubMed Simmonds MJ. GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis. Nat Rev Endocrinol. 2013;9:277–87.CrossRefPubMed
162.
go back to reference Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet. 2012;44:676–80. Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet. 2012;44:676–80.
163.
go back to reference Medici M, Porcu E, Pistis G, Teumer A, Brown SJ, Jensen RA, et al. Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease. PLoS Genet. 2014;10:e1004123. Medici M, Porcu E, Pistis G, Teumer A, Brown SJ, Jensen RA, et al. Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease. PLoS Genet. 2014;10:e1004123.
164.
go back to reference Alkhateeb A, Jarun Y, TasHashimoto thyroiditisoush R. Polymorphisms in NLRP1 gene and susceptibility to autoimmune thyroid disease. Autoimmunity. 2013;46:215–21.CrossRefPubMed Alkhateeb A, Jarun Y, TasHashimoto thyroiditisoush R. Polymorphisms in NLRP1 gene and susceptibility to autoimmune thyroid disease. Autoimmunity. 2013;46:215–21.CrossRefPubMed
165.
go back to reference Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C, Taylor M, et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet. 2002;11:661–7. Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C, Taylor M, et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet. 2002;11:661–7.
166.
go back to reference Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J, et al. A genome wide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet. 2003;72:1560–4. Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J, et al. A genome wide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet. 2003;72:1560–4.
167.
go back to reference Spritz RA, Gowan K, Bennett DC, Fain PR. Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet. 2004;74:188–91.CrossRefPubMedPubMedCentral Spritz RA, Gowan K, Bennett DC, Fain PR. Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet. 2004;74:188–91.CrossRefPubMedPubMedCentral
168.
go back to reference Schunter JA, Löffler D, Wiesner T, Kovacs P, Badenhoop K, Aust G, et al. Körner A. A novel FoxD3 variant is associated with vitiligo and elevated thyroid auto-antibodies. J Clin Endocrinol Metab. 2015;100:E1335–42. Schunter JA, Löffler D, Wiesner T, Kovacs P, Badenhoop K, Aust G, et al. Körner A. A novel FoxD3 variant is associated with vitiligo and elevated thyroid auto-antibodies. J Clin Endocrinol Metab. 2015;100:E1335–42.
169.
go back to reference Gong Q, Li X, Gong Q, Zhu W, Song G, Lu Y. Hashimoto’s thyroiditis could be secondary to vitiligo: the possibility of antigen crossover and oxidative stress between the two diseases. Arch Dermatol Res. 2016;308:277–81.CrossRefPubMed Gong Q, Li X, Gong Q, Zhu W, Song G, Lu Y. Hashimoto’s thyroiditis could be secondary to vitiligo: the possibility of antigen crossover and oxidative stress between the two diseases. Arch Dermatol Res. 2016;308:277–81.CrossRefPubMed
170.
go back to reference Slominski A, Wortsman J, Kohn L, Ain KB, Venkataraman GM, Pisarchik A, et al. Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J Invest Dermatol. 2002;119:1449–55. Slominski A, Wortsman J, Kohn L, Ain KB, Venkataraman GM, Pisarchik A, et al. Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J Invest Dermatol. 2002;119:1449–55.
171.
go back to reference Cianfarani F, Baldini E, Cavalli A, Marchioni E, Lembo L, Teson M, et al. TSH receptor and thyroid-specific gene expression in human skin. J Invest Dermatol. 2010;130:93–101. Cianfarani F, Baldini E, Cavalli A, Marchioni E, Lembo L, Teson M, et al. TSH receptor and thyroid-specific gene expression in human skin. J Invest Dermatol. 2010;130:93–101.
172.
go back to reference Ellerhorst JA, Sendi-Naderi A, Johnson MK, Cooke CP, Dang SM, Diwan AH. Human melanoma cells express functional receptors for thyroid-stimulating hormone. Endocr Relat Cancer. 2006;13:1269–77.CrossRefPubMed Ellerhorst JA, Sendi-Naderi A, Johnson MK, Cooke CP, Dang SM, Diwan AH. Human melanoma cells express functional receptors for thyroid-stimulating hormone. Endocr Relat Cancer. 2006;13:1269–77.CrossRefPubMed
173.
go back to reference Pattwell Dm LKJ, Watson RE, Paus R. HaCaT keratinocytes express functionalreceptors for thyroid-stimulating hormone. J Dermatol Sci. 2010;59:52–5.CrossRefPubMed Pattwell Dm LKJ, Watson RE, Paus R. HaCaT keratinocytes express functionalreceptors for thyroid-stimulating hormone. J Dermatol Sci. 2010;59:52–5.CrossRefPubMed
174.
go back to reference Bodó E, Kany B, Gáspár E, Knüver J, Kromminga A, Ramot Y, et al. Thyroid-stimulating hormone, a novel, locally produced modulator of human epidermal functions, is regulated by thyrotropin-releasing hormone and thyroid hormones. Endocrinology. 2010;151:1633–42. Bodó E, Kany B, Gáspár E, Knüver J, Kromminga A, Ramot Y, et al. Thyroid-stimulating hormone, a novel, locally produced modulator of human epidermal functions, is regulated by thyrotropin-releasing hormone and thyroid hormones. Endocrinology. 2010;151:1633–42.
175.
go back to reference Vidali S, Knuever J, Lerchner J, Giesen M, Bíró T, Klinger M, et al. Hypothalamic-pituitary-thyroid axis hormones stimulate mitochondrial function and biogenesis in human hair follicles. J Invest Dermatol. 2014;134:33–42. Vidali S, Knuever J, Lerchner J, Giesen M, Bíró T, Klinger M, et al. Hypothalamic-pituitary-thyroid axis hormones stimulate mitochondrial function and biogenesis in human hair follicles. J Invest Dermatol. 2014;134:33–42.
176.
go back to reference Bodó E, Kromminga A, Bíró T, Borbíró I, Gáspár E, Zmijewski MA, et al. Human female hair follicles are a direct, nonclassical target for thyroid-stimulating hormone. J Invest Dermatol. 2009;129:1126–39. Bodó E, Kromminga A, Bíró T, Borbíró I, Gáspár E, Zmijewski MA, et al. Human female hair follicles are a direct, nonclassical target for thyroid-stimulating hormone. J Invest Dermatol. 2009;129:1126–39.
177.
go back to reference Silvares MR, Fortes MR, Nascimento RA, Padovani CR, Miot HA, Nogueira CR, et al. Thyrotropin receptor gene expression in the association between chronic spontaneous urticaria and Hashimoto's thyroiditis. Int J Dermatol. 2017;56:547–52. Silvares MR, Fortes MR, Nascimento RA, Padovani CR, Miot HA, Nogueira CR, et al. Thyrotropin receptor gene expression in the association between chronic spontaneous urticaria and Hashimoto's thyroiditis. Int J Dermatol. 2017;56:547–52.
178.
go back to reference AltricHashimoto thyroiditiser S, Peter HJ, Pisarevskaja D, Metz M, Martus P, Maurer M. IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria? PLoS One. 2011;6:e14794.CrossRef AltricHashimoto thyroiditiser S, Peter HJ, Pisarevskaja D, Metz M, Martus P, Maurer M. IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria? PLoS One. 2011;6:e14794.CrossRef
179.
180.
go back to reference Burman KD, Mckinley-Grant L. Dermatologic aspects of thyroid disease. Clin Dermatol. 2006;24:247–55.CrossRefPubMed Burman KD, Mckinley-Grant L. Dermatologic aspects of thyroid disease. Clin Dermatol. 2006;24:247–55.CrossRefPubMed
181.
go back to reference Hanley K, Rassner U, Elias PM, Williams ML, Feingold KR. Epidermal barrier ontogenesis: maturation in serum-free media and acceleration by glucocorticoid and thyroid hormone but not selected growth factors. J Invest Dermatol. 1996;106:404–11.CrossRefPubMed Hanley K, Rassner U, Elias PM, Williams ML, Feingold KR. Epidermal barrier ontogenesis: maturation in serum-free media and acceleration by glucocorticoid and thyroid hormone but not selected growth factors. J Invest Dermatol. 1996;106:404–11.CrossRefPubMed
182.
go back to reference Tomić-Canić M, Day D, Samuels HH, Freedberg IM, Blumenberg M. Novel regulation of keratin gene expression by thyroid hormone and retinoid receptor. J Biol Chem. 1996;271:1416–23.CrossRefPubMed Tomić-Canić M, Day D, Samuels HH, Freedberg IM, Blumenberg M. Novel regulation of keratin gene expression by thyroid hormone and retinoid receptor. J Biol Chem. 1996;271:1416–23.CrossRefPubMed
183.
go back to reference Kömüves LG, Hanley K, Jiang Y, Elias PM, Williams ML, Feingold KR. Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J Invest Dermatol. 1998;111:429–33.CrossRefPubMed Kömüves LG, Hanley K, Jiang Y, Elias PM, Williams ML, Feingold KR. Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J Invest Dermatol. 1998;111:429–33.CrossRefPubMed
184.
go back to reference Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev. 2000;21:457–87.PubMed Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev. 2000;21:457–87.PubMed
185.
go back to reference Safer JD, Crawford TM, Holick MF. A role for thyroid hormone in wound healing through keratin gene expression. Endocrinology. 2004;145:2357–61.CrossRefPubMed Safer JD, Crawford TM, Holick MF. A role for thyroid hormone in wound healing through keratin gene expression. Endocrinology. 2004;145:2357–61.CrossRefPubMed
186.
go back to reference Radoja N, Stojadinovic O, Waseem A, Tomic-Canic M, Milisavljevic V, Teebor S, et al. Thyroid hormone and gamma interferon specifically increase K15 keratin gene transcription. Mol Cell Biol. 2004;24:3168–79. Radoja N, Stojadinovic O, Waseem A, Tomic-Canic M, Milisavljevic V, Teebor S, et al. Thyroid hormone and gamma interferon specifically increase K15 keratin gene transcription. Mol Cell Biol. 2004;24:3168–79.
187.
go back to reference Refetoff S, Matalon R, Bigazzi M. Metabolism of L-thyroxine (T4) and L-triiodothyronine (T3) by human fibroblasts in tissue culture: evidence for cellular binding proteins and conversion of T4 to T3. Endocrinology. 1972;91:934–47.CrossRefPubMed Refetoff S, Matalon R, Bigazzi M. Metabolism of L-thyroxine (T4) and L-triiodothyronine (T3) by human fibroblasts in tissue culture: evidence for cellular binding proteins and conversion of T4 to T3. Endocrinology. 1972;91:934–47.CrossRefPubMed
188.
go back to reference Huang TS, Chopra IJ, Beredo A, Solomon DH, Chua Teco GN. Skin is an active site for the inner ring monodeiodination of thyroxine to 3,3’,5’-triiodiothyronine. Endocrinology. 1985;17:2106–13.CrossRef Huang TS, Chopra IJ, Beredo A, Solomon DH, Chua Teco GN. Skin is an active site for the inner ring monodeiodination of thyroxine to 3,3’,5’-triiodiothyronine. Endocrinology. 1985;17:2106–13.CrossRef
189.
go back to reference Torma H, Karlsson T, Michaelsson G, Rollman O, Vahlquist A. Decreased mRNA levels of retinoic acid receptor alpha, retinoid X receptor alpha and thyroid hormone receptor alpha in lesional psoriatic skin. Acta Derm Venereol. 2000;80:4–9.CrossRefPubMed Torma H, Karlsson T, Michaelsson G, Rollman O, Vahlquist A. Decreased mRNA levels of retinoic acid receptor alpha, retinoid X receptor alpha and thyroid hormone receptor alpha in lesional psoriatic skin. Acta Derm Venereol. 2000;80:4–9.CrossRefPubMed
190.
go back to reference Billoni N, Buan B, Gautier B, Gaillard O, Mahe YF, Bernhard BA. Thyroid hormone receptor β1 is expressed in the human hair follicle. Br J Dermatol. 2000;142:645–52.CrossRefPubMed Billoni N, Buan B, Gautier B, Gaillard O, Mahe YF, Bernhard BA. Thyroid hormone receptor β1 is expressed in the human hair follicle. Br J Dermatol. 2000;142:645–52.CrossRefPubMed
191.
go back to reference Dentice M, Luongo C, Huang S, Ambrosio R, Elefante A, Mirebeau-Prunier D, et al. Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci USA. 2007;104:14466–71. Dentice M, Luongo C, Huang S, Ambrosio R, Elefante A, Mirebeau-Prunier D, et al. Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci USA. 2007;104:14466–71.
Metadata
Title
Thyroid diseases and skin autoimmunity
Authors
Enke Baldini
Teresa Odorisio
Chiara Tuccilli
Severino Persechino
Salvatore Sorrenti
Antonio Catania
Daniele Pironi
Giovanni Carbotta
Laura Giacomelli
Stefano Arcieri
Massimo Vergine
Massimo Monti
Salvatore Ulisse
Publication date
01-12-2018
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 4/2018
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-018-9450-7

Other articles of this Issue 4/2018

Reviews in Endocrine and Metabolic Disorders 4/2018 Go to the issue